Inventor

VIGNATI LOUIS

US6 patents

⚠️ This page may combine multiple inventors who share the name “VIGNATI LOUIS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LILLY CO ELI

5 patents

US7223728B2May 29, 2007

Synergistic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat metabolic instability associated with non-insulin dependent diabetes

LILLY CO ELI62 citations94

US6284751B1Sep 4, 2001

Method for treating non-insulin dependent diabetes using thiazolidinediones with glucagonlike peptide-1 and agonists thereof

LILLY CO ELI0 citations48

VIGNATI LOUIS

1 patent

US8975223B2Mar 10, 2015

Methods for treating metabolic disorders and obesity with a peptide comprising the amino acid sequence of SEQ ID No. 146

VIGNATI LOUIS38 citations90

VIGNATI LOUIS

LILLY CO ELI

Synergistic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat metabolic instability associated with non-insulin dependent diabetes

Therapeutic treatment for VEGF related diseases

Therapeutic treatment for VEGF related ocular diseases

Therapeutic treatment for skin disorders

Method for treating non-insulin dependent diabetes using thiazolidinediones with glucagonlike peptide-1 and agonists thereof

VIGNATI LOUIS

Methods for treating metabolic disorders and obesity with a peptide comprising the amino acid sequence of SEQ ID No. 146